These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7991853)

  • 1. [Ovarian hyperstimulation in women with fibrocystic mammary dysplasia treated with tamoxifen].
    Gallardo M; Vaccaro H
    Rev Chil Obstet Ginecol; 1993; 58(4):328-9. PubMed ID: 7991853
    [No Abstract]   [Full Text] [Related]  

  • 2. Ovarian cysts in tamoxifen-treated women with breast cancer.
    Inal MM; Incebiyik A; Sanci M; Yildirim Y; Polat M; Pilanci B; Nayki C; Camuzcuoğlu H
    Eur J Obstet Gynecol Reprod Biol; 2005 May; 120(1):104-6. PubMed ID: 15866095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian cyst formation in patients using tamoxifen for breast cancer.
    Metindir J; Aslan S; Bilir G
    Jpn J Clin Oncol; 2005 Oct; 35(10):607-11. PubMed ID: 16254040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian cysts in women receiving tamoxifen for breast cancer.
    Mourits MJ; de Vries EG; Willemse PH; ten Hoor KA; Hollema H; Sluiter WJ; de Bruijn HW; van der Zee AG
    Br J Cancer; 1999 Apr; 79(11-12):1761-4. PubMed ID: 10206289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian overstimulation and cystic formation in premenopausal tamoxifen exposure: comparison between tamoxifen-treated and nontreated breast cancer patients.
    Cohen I; Figer A; Tepper R; Shapira J; Altaras MM; Yigael D; Beyth Y
    Gynecol Oncol; 1999 Feb; 72(2):202-7. PubMed ID: 10021302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tamoxifen; wider indications, more frequent controls?].
    Rutgers EJ; Nortier JW; Beex I;
    Ned Tijdschr Geneeskd; 2001 Sep; 145(36):1766-7. PubMed ID: 11589197
    [No Abstract]   [Full Text] [Related]  

  • 7. Gonadotropin-releasing hormone agonists for the management of ovarian cysts in menopause breast cancer patients on tamoxifen treatment.
    Kourounis G; Zervoudis S; Michail G; Fotopoulos A
    Breast J; 2005; 11(5):365-6. PubMed ID: 16174165
    [No Abstract]   [Full Text] [Related]  

  • 8. Tamoxifen-associated ovarian cysts may be endometriomas.
    Thylan S
    Am J Obstet Gynecol; 1996 Sep; 175(3 Pt 1):752-3. PubMed ID: 8828450
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful management of an ovarian enlargement resembling ovarian hyperstimulation in a premenopausal breast cancer patient receiving tamoxifen with cotreatment of GnRH-agonist.
    Turan C; Unal O; Dansuk R; Guzelmeric K; Cengizoglu B; Esim E
    Eur J Obstet Gynecol Reprod Biol; 2001 Jul; 97(1):105-7. PubMed ID: 11435021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian cyst torsion and extreme ovarian stimulation in a premenopausal patient treated with tamoxifen for ductal carcinoma in situ of the breast.
    Taran A; Eggemann H; Costa SD; Smith B; Bischoff J
    Am J Obstet Gynecol; 2006 Oct; 195(4):e5-6. PubMed ID: 17000228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypoid endometriosis and other benign gynaecological complications associated with Tamoxifen therapy-a case to illustrate features on magnetic resonance imaging.
    Kraft JK; Hughes T
    Clin Radiol; 2006 Feb; 61(2):198-201. PubMed ID: 16439226
    [No Abstract]   [Full Text] [Related]  

  • 12. Ovarian cyst formation in two pre-menopausal patients treated with tamoxifen for breast cancer.
    Shulman A; Cohen I; Altaras MM; Maymon R; Ben-Nun I; Tepper R; Beyth Y
    Hum Reprod; 1994 Aug; 9(8):1427-9. PubMed ID: 7989499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen effects on treatment fibrocystic breast disease in women.
    Mousavi SR; Rezaei M
    Saudi Med J; 2006 Apr; 27(4):565-6. PubMed ID: 16598346
    [No Abstract]   [Full Text] [Related]  

  • 14. Ovarian cysts in tamoxifen-treated premenopausal women with breast cancer--a management dilemma.
    Hochner-Celnikier D; Anteby E; Yagel S
    Am J Obstet Gynecol; 1995 Apr; 172(4 Pt 1):1323-4. PubMed ID: 7726283
    [No Abstract]   [Full Text] [Related]  

  • 15. Medical management of mammary dysplasia.
    London RS; Sundaram GS; Goldstein PJ
    Obstet Gynecol; 1982 Apr; 59(4):519-23. PubMed ID: 7043344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tamoxifen; wider indications, more frequent controls?].
    Mourits MJ; van der Zee AG; Willemse PH; de Vries EG
    Ned Tijdschr Geneeskd; 2001 Sep; 145(36):1766-7. PubMed ID: 11572184
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of tamoxifen in the prevention and treatment of benign and malignant breast lesions: a chemopreventive.
    Leis HP
    Int Surg; 1993; 78(2):176-82. PubMed ID: 8354620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian torsion in a premenopausal woman treated with tamoxifen for breast cancer.
    Barbieri RL; Ferracci AL; Droesch JN; Rochelson BL
    Fertil Steril; 1993 Feb; 59(2):459-60. PubMed ID: 8425650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tamoxifen: does a wider range of indications require more careful monitoring?].
    Vogel NE; ter Brugge HG; de Graaf JC; Pierik EG
    Ned Tijdschr Geneeskd; 2001 Jun; 145(22):1041-3. PubMed ID: 11414162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent ependymoma treated with high-dose tamoxifen in a peripubertal female: Impact on tumor and the pituitary-ovarian axis.
    Yoffe R; Khakoo Y; Dunkel IJ; Souweidane M; Lis E; Sklar C
    Pediatr Blood Cancer; 2007 Oct; 49(5):758-60. PubMed ID: 16261561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.